Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

[Marketwired] – The Medicines Company today reported a presentation of a pooled analysis of 5,800 patients in the EUROMAX and HORIZONS-AMI trials, two international clinical trials comparing Angiomax® versus heparin with … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view